Format

Send to

Choose Destination
Sci Rep. 2018 Nov 23;8(1):17449. doi: 10.1038/s41598-018-36016-9.

Publisher Correction: Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.

Author information

1
Eaton-Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and Ear, Boston, MA, 02114, USA.
2
Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston, MA, 02115, USA.
3
Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA, 02115, USA.
4
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
5
Department of Otolaryngology, Harvard Medical School, Boston, MA, 02114, USA.
6
Department of Otolaryngology, Vienna General Hospital, Medical University of Vienna, Vienna, 1090, Austria.
7
Center for Experimental Drugs and Diagnostics, Department of Psychiatry and Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
8
Eaton-Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and Ear, Boston, MA, 02114, USA. konstantina_stankovic@meei.harvard.edu.
9
Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston, MA, 02115, USA. konstantina_stankovic@meei.harvard.edu.
10
Department of Otolaryngology, Harvard Medical School, Boston, MA, 02114, USA. konstantina_stankovic@meei.harvard.edu.

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center